Did anyone else (besides me) find it interesting that BMRN acquired all of RNA rather then work out some sort of licensing deal? From the call it was pretty clear that BMRN's interest at this time was only in acquiring Drisapersen.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.